Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Resectable Cervical Carcinoma With PET/MRI

NCT04219904 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04219904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Resectable Cervical Carcinoma With PET/MRI
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 7, 2018
Completion date
September 30, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia cervical cancer, stage ia1 cervical cancer, stage ia2 cervical cancer, stage ib cervical cancer, stage ib1 cervical cancer, stage ib2 cervical cancer, stage ib3 cervical cancer